Tyrosine kinase inhibitors of FGFR3 mutants [cytosol]

Stable Identifier
R-ALL-2077416
Type
Set [DefinedSet]
Compartment
Locations in the PathwayBrowser
Literature References
PubMed ID Title Journal Year
15598814 CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma

Trudel, S, Li, ZH, Wei, E, Wiesmann, M, Chang, H, Chen, C, Reece, D, Heise, C, Stewart, AK

Blood 2005
16091734 FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies

Chen, J, Lee, BH, Williams, I, Kutok, J, Mitsiades, CS, Duclos, N, Cohen, S, Adelsperger, J, Okabe, R, Coburn, A, Moore, S, Huntly, BJ, Fabbro, D, Anderson, KC, Griffin, J, Gilliland, DG

Oncogene 2005
14871245 Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma

Paterson, JL, Li, Z, Wen, XY, Masih-Khan, E, Chang, H, Pollett, JB, Trudel, S, Stewart, AK

Br J Haematol 2004
14715624 Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma

Trudel, S, Ely, S, Farooqi, Y, Affer, M, Robbiani, DF, Chesi, M, Bergsagel, PL

Blood 2004
15029211 Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074

Grand, EK, Chase, AJ, Heath, C, Rahemtulla, A, Cross, NC

Leukemia 2004
Participants
Participant Of
Disease
Name Identifier Synonyms
cancer 162 malignant tumor, malignant neoplasm, primary cancer
Cite Us!